These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1341990)

  • 1. Recombinant interferon gamma for treatment of chronic granulomatous disease and other disorders.
    Bolinger AM; Taeubel MA
    Clin Pharm; 1992 Oct; 11(10):834-50; quiz 892-4. PubMed ID: 1341990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular and molecular effects of recombinant interferon gamma in chronic granulomatous disease.
    Newburger PE; Ezekowitz RA
    Hematol Oncol Clin North Am; 1988 Jun; 2(2):267-76. PubMed ID: 2839459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of the autosomal recessive forms of chronic granulomatous disease.
    Curnutte JT
    Immunodefic Rev; 1992; 3(2):149-72. PubMed ID: 1554499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biological properties and clinical applications of interferon gamma (IFN-gamma)].
    Robak T
    Acta Haematol Pol; 1994; 25(1):19-29. PubMed ID: 8209610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of metastatic renal cell carcinoma patients with recombinant human gamma interferon.
    Small EJ; Weiss GR; Malik UK; Walther PJ; Johnson D; Wilding G; Kuzel T; Bajamonde A; Paton V
    Cancer J Sci Am; 1998; 4(3):162-7. PubMed ID: 9612597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
    Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant interferon gamma in the treatment of metastatic renal cell carcinoma. Results of a phase II trial.
    Otto U; Conrad S; Schneider AW; Klosterhalfen H
    Arzneimittelforschung; 1988 Nov; 38(11):1658-60. PubMed ID: 3145743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma.
    Ezekowitz RA; Dinauer MC; Jaffe HS; Orkin SH; Newburger PE
    N Engl J Med; 1988 Jul; 319(3):146-51. PubMed ID: 2838754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects.
    Weiner LM; Li W; Holmes M; Catalano RB; Dovnarsky M; Padavic K; Alpaugh RK
    Cancer Res; 1994 Aug; 54(15):4084-90. PubMed ID: 8033141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the IFN-gamma-induced enhancement of superoxide production in CGD-phagocytes caused by increased expression of the p47-phox cytosolic protein.
    Jendrossek V; Damm U; Liese J; Belohradsky BH; Gahr M
    Immunodeficiency; 1993; 4(1-4):187-90. PubMed ID: 8167697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility and pharmacokinetics of continuous subcutaneous infusion of low-dose interferon-gamma: a pilot study.
    Satake I; Tari K; Nakagomi K; Ozawa K
    Jpn J Clin Oncol; 1993 Dec; 23(6):356-62. PubMed ID: 8283789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease.
    Ezekowitz RA; Orkin SH; Newburger PE
    J Clin Invest; 1987 Oct; 80(4):1009-16. PubMed ID: 2821069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful interferon gamma therapy in a patient with X-linked chronic granulomatous disease, McLeod syndrome and hyper-IgE. Case report.
    Kantar A; Oggiano N; Gabbianelli R; Fabrizzi G; Giorgi PL
    Minerva Pediatr; 1994 Apr; 46(4):157-60. PubMed ID: 8084323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconstitution of defective phagocyte function in chronic granulomatous disease of childhood with recombinant human interferon-gamma.
    Gallin JI; Sechler JM; Malech HL
    Trans Assoc Am Physicians; 1988; 101():12-7. PubMed ID: 2855896
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics, single-dose tolerance, and biological activity of recombinant gamma-interferon in cancer patients.
    Kurzrock R; Rosenblum MG; Sherwin SA; Rios A; Talpaz M; Quesada JR; Gutterman JU
    Cancer Res; 1985 Jun; 45(6):2866-72. PubMed ID: 3921249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon in the treatment of myeloproliferative diseases.
    Silver RT
    Semin Hematol; 1990 Jul; 27(3 Suppl 4):6-14. PubMed ID: 2115694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic granulomatous disease.
    Dinauer MC; Orkin SH
    Annu Rev Med; 1992; 43():117-24. PubMed ID: 1316094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunological study of the postoperative adjuvant treatment with interferon gamma in patients with renal cell cancer--measurement of peripheral blood lymphocyte subsets with three color flow cytometry].
    Yasunaga Y; Nishimura K; Miura H; Takatera H; Kuroda H; Kishimoto T; Fujioka H
    Hinyokika Kiyo; 1995 Feb; 41(2):85-92. PubMed ID: 7702012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy for chronic granulomatous disease.
    Kume A; Dinauer MC
    J Lab Clin Med; 2000 Feb; 135(2):122-8. PubMed ID: 10695656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term interferon-gamma therapy for patients with chronic granulomatous disease.
    Marciano BE; Wesley R; De Carlo ES; Anderson VL; Barnhart LA; Darnell D; Malech HL; Gallin JI; Holland SM
    Clin Infect Dis; 2004 Sep; 39(5):692-9. PubMed ID: 15356785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.